Caption
: Recruiting trial
= 
; Ongoing trial
= 
-
- GERMANY
- Schleswig-Holstein
- BAD BRAMSTEDT
- A phase II, open label, prospective trial to evaluate the efficacy and safety of Mepolizumab for patients with refractory or relapsing Churg Strauss Syndrome
- Klinikum Bad Bramstedt GmbH
- Interdisziplinäres Vaskulitis-Zentrum des UKSH und des Klinikums BB
- More details
-
- NETHERLANDS
- Groningen
- GRONINGEN
- Prevention of Relapses in Proteinase 3 (PR3)-Anti-Neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
- UMCG - Universitair Medisch Centrum Groningen
- Universitair Medisch Centrum Groningen
- More details
